Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
ResMed Inc. (RMD) has a market cap of $33.61B with year-over-year revenue growth of +9.8%. Net margin stands at 27.2%. The stock trades at a P/E ratio of 24.0.
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, RMD posted revenue growth of +9.8% and trades at a P/E of 24.0.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.